Free Trial

Viemed Healthcare (VMD) Competitors

Viemed Healthcare logo
$6.61 +0.02 (+0.30%)
Closing price 04:00 PM Eastern
Extended Trading
$6.62 +0.01 (+0.23%)
As of 07:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VMD vs. CDNA, AVAH, VRDN, PNTG, GRAL, FTRE, CSTL, FLGT, AUNA, and TALK

Should you be buying Viemed Healthcare stock or one of its competitors? The main competitors of Viemed Healthcare include CareDx (CDNA), Aveanna Healthcare (AVAH), Viridian Therapeutics (VRDN), The Pennant Group (PNTG), Grail (GRAL), Fortrea (FTRE), Castle Biosciences (CSTL), Fulgent Genetics (FLGT), Auna (AUNA), and Talkspace (TALK). These companies are all part of the "healthcare" industry.

Viemed Healthcare vs.

Viemed Healthcare (NASDAQ:VMD) and CareDx (NASDAQ:CDNA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, community ranking, media sentiment, dividends, valuation, analyst recommendations and profitability.

CareDx received 439 more outperform votes than Viemed Healthcare when rated by MarketBeat users. Likewise, 65.87% of users gave CareDx an outperform vote while only 42.86% of users gave Viemed Healthcare an outperform vote.

CompanyUnderperformOutperform
Viemed HealthcareOutperform Votes
3
42.86%
Underperform Votes
4
57.14%
CareDxOutperform Votes
442
65.87%
Underperform Votes
229
34.13%

Viemed Healthcare has higher earnings, but lower revenue than CareDx. CareDx is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Viemed Healthcare$224.26M1.16$10.24M$0.2823.61
CareDx$333.79M3.18-$190.28M$1.0218.78

Viemed Healthcare has a net margin of 4.87% compared to CareDx's net margin of -45.90%. Viemed Healthcare's return on equity of 8.72% beat CareDx's return on equity.

Company Net Margins Return on Equity Return on Assets
Viemed Healthcare4.87% 8.72% 6.48%
CareDx -45.90%-53.70%-30.42%

In the previous week, CareDx had 8 more articles in the media than Viemed Healthcare. MarketBeat recorded 12 mentions for CareDx and 4 mentions for Viemed Healthcare. CareDx's average media sentiment score of 1.39 beat Viemed Healthcare's score of 1.04 indicating that CareDx is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Viemed Healthcare
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CareDx
10 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

CareDx has a consensus target price of $31.83, suggesting a potential upside of 66.14%. Given CareDx's higher possible upside, analysts plainly believe CareDx is more favorable than Viemed Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Viemed Healthcare
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00
CareDx
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.57

Viemed Healthcare has a beta of 1.64, suggesting that its share price is 64% more volatile than the S&P 500. Comparatively, CareDx has a beta of 2.18, suggesting that its share price is 118% more volatile than the S&P 500.

74.2% of Viemed Healthcare shares are owned by institutional investors. 20.0% of Viemed Healthcare shares are owned by insiders. Comparatively, 4.9% of CareDx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

CareDx beats Viemed Healthcare on 10 of the 19 factors compared between the two stocks.

Remove Ads
Get Viemed Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for VMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VMD vs. The Competition

MetricViemed Healthcarehealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ Exchange
Market Cap$261.24M$2.01B$5.33B$7.57B
Dividend YieldN/A7.14%5.11%4.33%
P/E Ratio24.4814.9221.8117.82
Price / Sales1.163.94379.3794.59
Price / Cash9.569.3238.1534.64
Price / Book2.234.096.464.00
Net Income$10.24M$87.49M$3.20B$247.23M
7 Day Performance-0.75%-1.61%6.63%7.25%
1 Month Performance-12.68%-8.89%-8.50%-6.24%
1 Year Performance-18.80%-26.38%10.47%-0.17%

Viemed Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VMD
Viemed Healthcare
0.9794 of 5 stars
$6.61
+0.3%
N/A-19.4%$261.24M$224.26M24.48630Short Interest ↑
Positive News
Gap Down
CDNA
CareDx
3.6475 of 5 stars
$17.72
+2.5%
$31.83
+79.6%
+121.6%$982.15M$333.79M-6.56740News Coverage
Positive News
Gap Down
AVAH
Aveanna Healthcare
0.8892 of 5 stars
$4.96
-1.4%
$4.94
-0.5%
+101.3%$967.67M$2.02B-14.5933,000Gap Down
High Trading Volume
VRDN
Viridian Therapeutics
1.0153 of 5 stars
$11.78
-1.8%
$35.70
+203.1%
-16.3%$959.89M$302,000.00-2.7350News Coverage
Positive News
Gap Down
PNTG
The Pennant Group
3.2759 of 5 stars
$24.35
-0.9%
$34.80
+42.9%
+28.9%$838.37M$695.24M35.815,340News Coverage
Gap Down
GRAL
Grail
0.5726 of 5 stars
$23.98
+7.8%
$20.00
-16.6%
N/A$812.80M$125.60M0.001,360Short Interest ↑
News Coverage
Positive News
Gap Down
FTRE
Fortrea
3.705 of 5 stars
$6.27
-2.9%
$19.00
+203.0%
-86.3%$565.55M$2.70B-1.8318,000Short Interest ↓
CSTL
Castle Biosciences
2.8788 of 5 stars
$19.09
+2.8%
$38.75
+103.0%
-0.8%$550.54M$332.07M95.45540News Coverage
FLGT
Fulgent Genetics
3.5023 of 5 stars
$17.10
+1.4%
$16.00
-6.4%
-8.8%$527.81M$283.47M-3.101,010Positive News
AUNA
Auna
3.6488 of 5 stars
$6.76
+0.1%
$13.53
+100.2%
-6.4%$499.32M$4.39B17.7814,958Short Interest ↑
Positive News
TALK
Talkspace
3.9438 of 5 stars
$2.65
+0.8%
$4.50
+69.8%
-19.8%$446.36M$187.59M265.27500Positive News
Remove Ads

Related Companies and Tools


This page (NASDAQ:VMD) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners